-
Drug combination leads to durable responses in patients with small cell lung cancer
-
Congratulations to CCR scientists, alumni recognized by AACR
-
Widemann recognized for clinical research achievement and elected to AAP
-
FDA grants orphan drug designation to PRGN-2012 for RRP
-
Combination therapy in patients with advanced kidney cancer found to be highly effective
